Skip to Content

Vietnamese study shows C-reactive protein testing significantly reduces inappropriate use of antibiotics

In the first study to investigate point-of-care CRP in low-income or middle-income countries, tests were provided to 10 primary healthcare centers in and around Hanoi, Vietnam.

Vietnamese study shows C-reactive protein testing significantly reduces inappropriate use of antibiotics

2037 patients presenting with non-severe acute respiratory tract infections were randomly selected to either receive a CRP test or to receive routine care. The results showed a significant reduction of antibiotic use in adults and children who received the CRP test while clinical recovery was the same. There was an overall absolute reduction of 14% in antibiotic use with a high degree of heterogeneity in the effect of CRP point-of-care testing across sites.

The results of this study reflect results observed in studies in Western Europe which also showed that the use of a point- of-care CRP test reduces antibiotic prescribing without negatively affecting clinical recovery.

According to the authors of the paper, “Our findings indicate that the intervention could be applied in the resource-constrained settings of low-income and middle-income countries to improve rational antibiotic use for both children and adults with non-severe acute respiratory tract infection without compromising patients' recovery and satisfaction. Considerable heterogeneity between the ten health-care stations indicates the importance of regular review of any intervention and tailoring it to specific local context.”

Read the full paper here: http://www.thelancet.com/journals/langlo/article/PIIS2214-109X(16)30142-5/fulltext

The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Abbott or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Abbott or TestTargetTreat.com. Neither Abbott nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.

Explore Related Content and Videos

C. difficile Patient Pathway

Which pathway would you choose for you patient?

Pick a pathway

ITV News Video

ITV News reports on the O'Neill Review and features the point-of-care Alere Afinion™ CRP test being used in primary care.

Webinar

Point of Care C-reactive Protein (CRP) Testing to Safely Reduce Inappropriate Antibiotic Use